Getinge will gradually phase out its surgical perfusion business, to focus on more profitable growth areas such as ECLS and ...

Normothermic machine perfusion (NMP) to preserve livers prior to transplant was associated with significantly improved ...

CEO Mattias Perjos said surgical perfusion has “been a struggling category” since an FDA consent decree forced Getinge off the U.S. market in 2015.

Paragonix Technologies, a pioneer in organ transplant technologies and organ procurement services, announced today the ...

LivaNova (LIVN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael Matson from ...

The data revealed that the use of the Trans-Arterial Micro-Perfusion (TAMP) device resulted in greater drug potency and fewer ...

GOTHENBURG, Sweden, Jan. 28, 2025 /PRNewswire/ -- "In 2024, Getinge had record sales and we finished off the year with a strong quarter. Both order intake and net sales increased significantly, also ...

TransMedics' stock remains under pressure after a weak third quarter, reduced Q4 guidance, the exit of the company's CFO, and the release of a short-seller report. Read more here.

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, toda ...

The MSc in Cardiovascular Perfusion provides a high-quality, research-led education that will equip you with enhanced knowledge, understanding and critical awareness of the current approaches and ...

This blended learning programme integrates academic knowledge and understanding of perfusion science with both the needs of the working professional clinical perfusion scientist and the demands of ...